The Hagedorn Prize was established by the Danish Society of Internal Medicine in 1966 to recognize the contribution to medical science made by Hans Christian Hagedorn (1888–1971).[4] The prize is awarded at the society's annual general meeting.[5]
Initially, the Hagedorn Prize received its endowment from a distinct foundation, funded by contributions from Nordisk Insulinlaboratorium, with the Board of the Danish Society for Internal Medicine serving as its governing body. However, by 2008, the foundation's resources were deemed inadequate to sustain a meaningful award. Consequently, the remaining capital was transferred to the Novo Nordisk Foundation, which subsequently assumed the responsibility of bestowing the Hagedorn Prize, while maintaining the ongoing involvement of the Society. The recipient of the prize is determined by the society's board, relying on recommendations provided by its members.[5]
The Danish Society of Internal Medicine, comprising nearly 4,500 members, serves as an overarching body for the nine internal medicine specialties within Denmark. Its objectives include the advancement of scientific research in internal medicine and the facilitation of ongoing education for specialist physicians in the discipline. Established in 1916, the Society operates with a board of directors composed of nine members, appointed by the boards of each respective internal medicine specialty.[6]
The Hagedorn Prize includes a monetary component, designed to support the ongoing research of the recipient. In addition, awardees are presented with a medal and a certificate recognizing their contributions to advancing diabetes research and treatment. The prize is intended not only to honor individuals for their past achievements but also to encourage further innovation and research in diabetes care.[5]